Showing 281 - 300 results of 4,407 for search '"pharmaceutical"', query time: 0.06s Refine Results
  1. 281
  2. 282
  3. 283
  4. 284
  5. 285
  6. 286

    Electrochemical Behaviour of Tinidazole at 1,4-Benzoquinone Modified Carbon Paste Electrode and Its Direct Determination in Pharmaceutical Tablets and Urine by Differential Pulse Voltammetry by Yosef Nikodimos, Beyene Hagos

    Published 2017-01-01
    “…Excellent recovery results for spiked TDZ in pharmaceutical tablet samples ranging within 97.44–97.51% and in urine ranging within 95.37–96.91% were observed. …”
    Get full text
    Article
  7. 287
  8. 288
  9. 289

    Pilot-Scale Removal of Trace Steroid Hormones and Pharmaceuticals and Personal Care Products from Municipal Wastewater Using a Heterogeneous Fenton’s Catalytic Process by George Tangyie Chi, John Churchley, Katherine D. Huddersman

    Published 2013-01-01
    “…The pollution of water sources by endocrine disrupting compounds (EDCs) and pharmaceutical and personal care products (PPCPs) is a growing concern, as conventional municipal wastewater treatment systems are not capable of completely removing these contaminants. …”
    Get full text
    Article
  10. 290
  11. 291

    Calculation of drug dosages : a work text / by Ogden, Sheila J., 1949-

    Published 2012
    Subjects: “…Pharmaceutical arithmetic Programmed instruction. 4734…”
    View in OPAC
    Book
  12. 292
  13. 293
  14. 294
  15. 295
  16. 296
  17. 297
  18. 298

    Bhavana, an Ayurvedic Pharmaceutical Method and a Versatile Drug Delivery Platform to Prepare Potentiated Micro-Nano-Sized Drugs: Core Concept and Its Current Relevance by Rohit Sharma, Prashant Bedarkar, Deepak Timalsina, Anand Chaudhary, Pradeep Kumar Prajapati

    Published 2022-01-01
    “…Despite the fact that Bhavana has a wide range of applications in Ayurvedic pharmaceutics, there is only a limited amount of knowledge of its fundamental notions. …”
    Get full text
    Article
  19. 299

    The Impact of Recent Generic Drug Price Policies on Pharmaceutical Innovation: A Theoretical Rationale and Proposal of a Method Supporting Innovation in Areas of Unmet Medical Need by Pierre-Alexandre Dionne, Farzad Ali, Mendel Grobler

    Published 2016-10-01
    “…New discoveries are a critical priority for the pharmaceutical industry. However, the use of fixed incremental cost-effectiveness (ICER) thresholds for health technology assessment (HTA) may compromise incentives to innovate and affect future treatment options. …”
    Get full text
    Article
  20. 300

    Did the resurgence of childhood lower respiratory infections offset the initial benefit of COVID-19-related non-pharmaceutical interventions in children? A time-series analysis by Inès Fafi, Zein Assad, Léa Lenglart, Zaba Valtuille, Florentia Kaguelidou, Camille Aupiais, Aurélie Bourmaud, Alexis Rybak, Stéphane Bechet, Corinne Levy, Robert Cohen, Bruno Frandji, Andreas Werner, François Angoulvant, Romain Basmaci, Naïm Ouldali

    Published 2025-02-01
    “…Abstract Background Following non-pharmaceutical interventions (NPI) lifting in 2021, an important surge in childhood lower respiratory tract infections (LRTI) was reported in several countries, raising major concerns about the middle-term consequences of such interventions. …”
    Get full text
    Article